Skip to main content
ImmuneCited

Quantification of anthocyanins in elderberry and chokeberry dietary supplements.

Christian Vlachojannis, Benno F Zimmermann, Sigrun Chrubasik-Hausmann
Other Phytotherapy research : PTR 2015 37 인용
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'pmid\u003D25597779'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

연구 유형
Other
대상 집단
men
중재
Quantification of anthocyanins in elderberry and chokeberry dietary supplements. 110 mg
대조군
None
일차 결과
None
효과 방향
Positive
비뚤림 위험
Unclear

Abstract

Elderberry and chokeberry food supplements may be 'functional food' in patients with metabolic syndrome or influenza but, for this, adequate amounts of co-active ingredients must be consumed in the daily dose. This study aimed to quantify the anthocyanin content in three elderberry and six chokeberry products to assess their usefulness as functional food. Analyses were carried out using an established HPLC procedure. The minimum anthocyanin doses for the treatment of metabolic syndrome disorders were estimated as 110 mg per day and 3.5 g per day for influenza. Three products were inappropriate for clinical use. The lowest liquid supplies were achieved with a proprietary elderberry concentrate (11 mL) and a proprietary chokeberry mother juice (100 mL). Clinical studies are now required to prove the effectiveness and adapt the doses according to the clinical symptoms.

요약

The anthocyanin content in three elderberry and six chokeberry products was quantified to assess their usefulness as functional food and clinical studies are now required to prove the effectiveness and adapt the doses according to the clinical symptoms.

Used In Evidence Reviews

Similar Papers